相关实验视频
Updated: Jun 25, 2025
08:41
Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
9.1K
向瘤微环境治疗双抗性慢性淋巴细胞白血病
Richard I Lewis1, Alexander F Vom Stein1, Michael Hallek1
1Department I of Internal Medicine, Faculty of Medicine, University of Cologne, University Hospital Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, Center for Molecular Medicine Cologne, CECAD Center of Excellence on Cellular Stress Responses in Aging-Associated Diseases, Cologne, Germany.
Blood
|May 22, 2024
概括
针对瘤微环境的新疗法为耐BTK抑制剂和BCL2抗剂耐药的慢性淋巴细胞白血病 (CLL) 患者提供了希望. 这种方法解决了CLL治疗的未满足需求.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
背景情况:
- 慢性淋巴细胞白血病 (CLL) 治疗已经通过布鲁顿的氨酸激酶 (BTK) 抑制剂和BCL2抗剂得到进展,成为治疗的标准.
- 这些新型药物显著改善了患者的治疗结果,在很大程度上取代了传统的化学免疫疗法.
- 现在,正在出现一组对BTK抑制剂和BCL2抗剂都不耐药或不耐受的CLL患者,这代表了严重的未满足的医疗需求.
研究的目的:
- 为患有双重耐药性疾病的慢性淋巴细胞白血病 (CLL) 患者提出新的治疗策略.
- 探索针对瘤微环境的潜力,作为耐火性CLL的新治疗途径.
- 概述了一种对双抗性CLL的顺序组合疗法方法.
主要方法:
- 审查和综合目前的治疗格局在CLL.
- 在CLL中针对瘤微环境的概念框架.
- 关于顺序组合治疗策略的建议.
主要成果:
- 确定一组患有双重耐火性CLL (对BTK抑制剂和BCL2抗剂) 的患者组.
- 建议调节瘤微环境可以克服对当前疗法的耐药性.
- 开发一个连续的,瘤微环境导向的组合治疗策略.
结论:
- 向瘤微环境为双抗性CLL患者提供了一个有希望的治疗途径.
- 针对瘤微环境的连续组合疗法需要临床研究.
- 解决耐火性CLL的未满足需求需要创新的治疗策略,超出目前的护理标准.
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:27Tumor Immunotherapy
515
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
515
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K